These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2468920)

  • 21. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.
    Lang R; Klein HO; Weiss E; David D; Sareli P; Levy A; Guerrero J; Di Segni E; Kaplinsky E
    Chest; 1983 Mar; 83(3):491-9. PubMed ID: 6337787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study.
    Tsuneda T; Yamashita T; Fukunami M; Kumagai K; Niwano S; Okumura K; Inoue H
    Circ J; 2006 Aug; 70(8):965-70. PubMed ID: 16864926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
    Platia EV; Michelson EL; Porterfield JK; Das G
    Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
    Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
    Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.
    Channer KS; James MA; MacConnell T; Rees JR
    Br J Clin Pharmacol; 1994 Jan; 37(1):53-7. PubMed ID: 7908532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
    Watanabe K; Hirokawa Y; Shibata A
    J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis.
    Panidis IP; Morganroth J; Baessler C
    Am J Cardiol; 1983 Dec; 52(10):1197-201. PubMed ID: 6359848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate.
    Gilligan DM; Stewart R; Chan WL; Oakley CM
    Int J Cardiol; 1992 Jun; 35(3):377-86. PubMed ID: 1351887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.
    Pomfret SM; Beasley CR; Challenor V; Holgate ST
    Clin Sci (Lond); 1988 Apr; 74(4):351-7. PubMed ID: 3281786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evidence regarding the drugs used for ventricular rate control.
    Segal JB; McNamara RL; Miller MR; Kim N; Goodman SN; Powe NR; Robinson K; Yu D; Bass EB
    J Fam Pract; 2000 Jan; 49(1):47-59. PubMed ID: 10678340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.
    Lewis RV; McDevitt DG
    Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological rate control of atrial fibrillation.
    Tamariz LJ; Bass EB
    Cardiol Clin; 2004 Feb; 22(1):35-45. PubMed ID: 14994846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional capacity of patients with atrial fibrillation and controlled heart rate before and after cardioversion.
    Kubac G; Malowany L
    Can J Cardiol; 1992 Nov; 8(9):941-6. PubMed ID: 1486544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
    Farshi R; Kistner D; Sarma JS; Longmate JA; Singh BN
    J Am Coll Cardiol; 1999 Feb; 33(2):304-10. PubMed ID: 9973007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.